Global Medications for Treating Alcohol Dependence Market Growth (Status and Outlook) 2025-2031

The global Medications for Treating Alcohol Dependence market size is predicted to grow from US$ 781 million in 2025 to US$ 1858 million in 2031; it is expected to grow at a CAGR of 15.5% from 2025 to 2031.

United States market for Medications for Treating Alcohol Dependence is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Medications for Treating Alcohol Dependence is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Medications for Treating Alcohol Dependence is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Medications for Treating Alcohol Dependence players cover Alkermes Inc, Merck Group, Lundbeck, Alvogen, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Medications for Treating Alcohol Dependence Industry Forecast” looks at past sales and reviews total world Medications for Treating Alcohol Dependence sales in 2024, providing a comprehensive analysis by region and market sector of projected Medications for Treating Alcohol Dependence sales for 2025 through 2031. With Medications for Treating Alcohol Dependence sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medications for Treating Alcohol Dependence industry.

This Insight Report provides a comprehensive analysis of the global Medications for Treating Alcohol Dependence landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medications for Treating Alcohol Dependence portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medications for Treating Alcohol Dependence market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medications for Treating Alcohol Dependence and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medications for Treating Alcohol Dependence.

This report presents a comprehensive overview, market shares, and growth opportunities of Medications for Treating Alcohol Dependence market by product type, application, key players and key regions and countries.

Segmentation by Type:
Naltrexone
Acamprosate
Disulfiram
Other

Segmentation by Application:
Hospital
Rehabilitation Institutions
Clinic
Retail Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alkermes Inc
Merck Group
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd

Please note: The report will take approximately 2 business days to prepare and deliver. Show more